1239908-20-3 Ixazomib citrate
| 상품명칭 |
Ixazomib citrate |
| 영문 이름 |
Ixazomib citrate; IXAZOMIB; IXAZOMIB CITRATE; 2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid; 2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid; (R)-2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid; 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid |
| 분자식 |
C20H23BCl2N2O9 |
| 분자량 |
517.12 |
| cas번호 |
1239908-20-3 |
| EC번호 |
C20H23BCl2N2O9 |
| 분자 구조 |
|
| 밀도 |
1.47±0.1 g/cm3(Predicted) |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
